跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 418 条关于
“Leukotriene C4 Synthase (LTC4S)”
全部
418
临床试验
176
药物
89
机构
5
资讯
148
25天前
Four-Gene Fatty Acid Metabolism Signature Distinguishes Diabetic Foot Ulcers With High Diagnostic Accuracy
去年
C4 Therapeutics Stock Hits 52-Week Low Amid Market Volatility
5个月前
C4 Therapeutics and Roche Expand Partnership with $1 Billion+ DAC Collaboration
去年
C4 Therapeutics Announces 2025 Milestones for Oncology-Focused Degrader Medicines
3个月前
FDA Approves Baxfendy (Baxdrostat), a Novel Aldosterone Synthase Inhibitor for Resistant Hypertension
2年前
C4 Therapeutics' CFT1946 Shows Promise in BRAF V600 Mutant Solid Tumors
8个月前
C4 Therapeutics Advances Cemsidomide Through Phase 2 Development as Potential Best-in-Class Multiple Myeloma Treatment
2个月前
Beyond the Pill: RNA Interference, Aldosterone Synthase Inhibition and Incretins Reshape Hypertension Drug Development
去年
FDA Accepts IND Application for BIIB142, First IRAK4 Degrader to Enter Clinical Development for Autoimmune Diseases
去年
Montelukast (Singulair) Linked to Psychiatric Effects by FDA Researchers
第 1 页，共 15 页
上一页
下一页
